Scarica l'app Stockscreener
10.31
7.20%
-0.80
Dopo l'orario di chiusura:
10.20
-0.11
-1.07%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GLUE Giù?
Forum
Previsione
Precedente Chiudi:
$11.11
Aprire:
$11.23
Volume 24 ore:
857.23K
Relative Volume:
0.72
Capitalizzazione di mercato:
$636.74M
Reddito:
-
Utile/perdita netta:
$-130.41M
Rapporto P/E:
-4.6027
EPS:
-2.24
Flusso di cassa netto:
$-67.76M
1 W Prestazione:
+21.87%
1M Prestazione:
+59.35%
6M Prestazione:
+133.79%
1 anno Prestazione:
+87.45%
Intervallo 1D:
$10.20
$11.47
Intervallo di 1 settimana:
$8.525
$11.47
Portata 52W:
$3.5001
$12.40
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Nome
Monte Rosa Therapeutics Inc
Settore
Industria
Telefono
617-949-2643
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta GLUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
10.31 | 655.27M | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-15 | Iniziato | Wedbush | Outperform |
| 2023-01-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Iniziato | UBS | Buy |
| 2022-08-15 | Iniziato | Jefferies | Buy |
| 2022-04-28 | Iniziato | Credit Suisse | Neutral |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-10-14 | Iniziato | SVB Leerink | Mkt Perform |
Mostra tutto
Monte Rosa Therapeutics Inc Borsa (GLUE) Ultime notizie
Monte Rosa Therapeutics, Inc. Experiences Valuation Adjustment Amid Strong Market Performance - Markets Mojo
Day 6 of Gains Streak for Monte Rosa Therapeutics Stock with 51% Return (vs. 60% YTD) [10/15/2025] - Trefis
Custom watchlist performance reports with Monte Rosa Therapeutics Inc.July 2025 Market Mood & Safe Entry Point Alerts - newser.com
Why Monte Rosa Therapeutics Inc. stock could benefit from AI revolutionJuly 2025 Update & Weekly Stock Breakout Alerts - newser.com
Using economic indicators to assess Monte Rosa Therapeutics Inc. potentialMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Applying sector rotation models to Monte Rosa Therapeutics Inc.2025 Market Overview & High Accuracy Swing Entry Alerts - newser.com
Why Monte Rosa Therapeutics Inc. stock is popular among millennials2025 Volatility Report & Daily Profit Maximizing Tips - newser.com
Using data models to predict Monte Rosa Therapeutics Inc. stock movementEarnings Beat & High Accuracy Buy Signal Tips - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Monte Rosa Therapeutics (NASDAQ:GLUE) Trading Up 7.9%Here's Why - MarketBeat
Monte Rosa Therapeutics Inc. stock momentum explainedWeekly Gains Summary & Verified Entry Point Signals - newser.com
What analysts say about Monte Rosa Therapeutics Inc stockValue Traps to Avoid & Outstanding Growth Strategies - earlytimes.in
Does Monte Rosa Therapeutics Inc. fit your quant trading modelJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Monte Rosa Therapeutics Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
Signal strength of Monte Rosa Therapeutics Inc. stock in tech scannersDollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Monte Rosa Therapeutics (NASDAQ:GLUE) Earns "Sell (D)" Rating from Weiss Ratings - MarketBeat
Will Monte Rosa Therapeutics Inc. see short term momentum2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Comparing Monte Rosa Therapeutics Inc. in custom built stock radarsJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
How high can Monte Rosa Therapeutics Inc. stock goShort Setup & Advanced Technical Analysis Signals - newser.com
Pallas Capital Backs Monte Rosa Therapeutics, Inc. (GLUE) Amid Growth Prospects - Insider Monkey
11 Best Fast Money Stocks to Buy Now - Insider Monkey
Is Monte Rosa Therapeutics Inc a good long term investmentGeopolitical Risk Analysis & Consistent Double Returns - earlytimes.in
Monte Rosa Therapeutics Inc Stock Analysis and ForecastLarge Cap Stability Picks & Fast Profit Trading Ideas - earlytimes.in
Full technical analysis of Monte Rosa Therapeutics Inc. stockBuy Signal & Accurate Buy Signal Notifications - newser.com
Is Monte Rosa Therapeutics Inc. stock reversal real or fakeWatch List & Daily Chart Pattern Signals - newser.com
Monte Rosa Therapeutics Inc. stock trend forecastJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com
Pallas Capital Advisors LLC Makes New $59,000 Investment in Monte Rosa Therapeutics, Inc. $GLUE - Defense World
Monte Rosa Therapeutics presents new CDK2 degradation inducers - BioWorld MedTech
Monte Rosa Is Building The ‘Next RNAi’ Through AI-Powered Molecular Glue Discovery - insights.citeline.com
Monte Rosa Therapeutics Inc Azioni (GLUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Monte Rosa Therapeutics Inc Azioni (GLUE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Leo Chandra P. | Director |
Mar 24 '25 |
Buy |
5.84 |
10,000 |
58,383 |
10,000 |
| Versant Venture Capital VI, L. | 10% Owner |
Oct 28 '24 |
Sale |
9.66 |
89,990 |
869,240 |
2,007,948 |
| Versant Venture Capital VI, L. | 10% Owner |
Oct 29 '24 |
Sale |
9.16 |
67,905 |
621,801 |
1,573,453 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):